56
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis.

      Science (New York, N.Y.)
      Animals, Chemokines, metabolism, Cytokines, Inflammation Mediators, Leishmania guyanensis, pathogenicity, virology, Leishmaniasis, Mucocutaneous, immunology, parasitology, Leishmaniavirus, physiology, Macrophages, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Parasitemia, Phagosomes, RNA, Double-Stranded, RNA, Viral, Toll-Like Receptor 3, Toll-Like Receptors

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mucocutaneous leishmaniasis is caused by infections with intracellular parasites of the Leishmania Viannia subgenus, including Leishmania guyanensis. The pathology develops after parasite dissemination to nasopharyngeal tissues, where destructive metastatic lesions form with chronic inflammation. Currently, the mechanisms involved in lesion development are poorly understood. Here we show that metastasizing parasites have a high Leishmania RNA virus-1 (LRV1) burden that is recognized by the host Toll-like receptor 3 (TLR3) to induce proinflammatory cytokines and chemokines. Paradoxically, these TLR3-mediated immune responses rendered mice more susceptible to infection, and the animals developed an increased footpad swelling and parasitemia. Thus, LRV1 in the metastasizing parasites subverted the host immune response to Leishmania and promoted parasite persistence.

          Related collections

          Author and article information

          Comments

          Comment on this article